Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls
- PMID: 26850415
- DOI: 10.1007/s40618-015-0421-5
Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls
Abstract
Background: Bone turnover markers have a potential clinical use in describing bone remodeling and in predicting fractures.
Aims: In an elderly population ≥75 years with a fresh hip fracture, and in healthy controls, investigate bone turnover markers and their relation to each other, to vitamin D status and to bone mineral density (BMD).
Methods: In a cross-sectional study serum levels of dickkopf-1 (DKK-1), sclerostin (SOST), osteoprotegerin (OPG), osteopontin (OPN), osteocalcin, 25-hydroxyvitamin D (25(OH)D) were analyzed in 89 Swedish patients with a fresh hip fracture and in 82 healthy volunteers. Serum levels of bone markers were determined by Luminex technique.
Results: S-25-hydroxyvitamin D (S-25(OH)D) was decreased in patients compared to controls (48 ± 21 vs. 76 ± 25 nmol/L, p < 0.001). SOST, but none of the other bone turnover markers correlated with BMD (r = 0.50, p < 0.001). Compared with controls, higher levels of OPG (488 ± 1.4 vs. 191 ± 1.4 ng/L, p < 0.001), OPN (69 ± 1.7 vs. 19 ± 1.4 µg/L, p < 0.001), DKK-1 (273 ± 1.7 vs. 168 ± 1.7 ng/L, p < 0.001), and lower levels of osteocalcin (5.8 ± 3.5 vs. 9.5 ± 3.6 µg/L, p < 0.001), were found in the fracture group. Levels of OPG, DKK-1 and SOST in both groups were positively associated. S-25(OH)D concentration was not found to be strongly associated with any of the bone markers.
Conclusions: In contrast to findings in other studies, we found no strong correlation between 25(OH)D and the investigated bone markers. Both in patients with a fresh hip fracture and in healthy elderly, DKK-1, SOST and OPG appear to be associated. This suggests a relevance in these relationships meriting further investigation.
Keywords: Bone mineral density; DXA; Magpix; Osteoporosis; PTH; Vitamin D deficiency.
Similar articles
-
Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.Osteoporos Int. 2017 Sep;28(9):2683-2689. doi: 10.1007/s00198-017-4104-2. Epub 2017 Jun 5. Osteoporos Int. 2017. PMID: 28585053
-
Alterations in bone turnover markers in patients with noncardio-embolic ischemic stroke.PLoS One. 2018 Nov 29;13(11):e0207348. doi: 10.1371/journal.pone.0207348. eCollection 2018. PLoS One. 2018. PMID: 30496210 Free PMC article. Clinical Trial.
-
Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.Biomed Res Int. 2021 Aug 30;2021:5567666. doi: 10.1155/2021/5567666. eCollection 2021. Biomed Res Int. 2021. PMID: 34497849 Free PMC article.
-
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.Nephrol Dial Transplant. 2015 Aug;30(8):1345-56. doi: 10.1093/ndt/gfv081. Epub 2015 Apr 7. Nephrol Dial Transplant. 2015. PMID: 25854266 Review.
-
Circulating Levels of Osteoprotegerin, Osteocalcin and Osteopontin in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.Immunol Invest. 2019 Feb;48(2):107-120. doi: 10.1080/08820139.2018.1510957. Epub 2018 Sep 6. Immunol Invest. 2019. PMID: 30188218
Cited by
-
Clinical Data for Parametrization of In Silico Bone Models Incorporating Cell-Cytokine Dynamics: A Systematic Review of Literature.Front Bioeng Biotechnol. 2022 Jul 12;10:901720. doi: 10.3389/fbioe.2022.901720. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35910035 Free PMC article.
-
Body composition and circulating estradiol are the main bone density predictors in healthy young and middle-aged men.J Endocrinol Invest. 2018 Aug;41(8):995-1003. doi: 10.1007/s40618-018-0826-z. Epub 2018 Jan 16. J Endocrinol Invest. 2018. PMID: 29336002
-
Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration.Biomedicines. 2023 May 29;11(6):1574. doi: 10.3390/biomedicines11061574. Biomedicines. 2023. PMID: 37371669 Free PMC article.
-
Circulating bioactive sclerostin levels in an Austrian population-based cohort.Wien Klin Wochenschr. 2022 Jan;134(1-2):39-44. doi: 10.1007/s00508-021-01815-0. Epub 2021 Feb 5. Wien Klin Wochenschr. 2022. PMID: 33544208 Free PMC article.
-
Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly.Front Endocrinol (Lausanne). 2024 Dec 17;15:1472680. doi: 10.3389/fendo.2024.1472680. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39741885 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous